The clinical impact of PCR-based point-of-care diagnostic in respiratory tract infections in children.
Biofire® FilmArray®
acute respiratory tract infections
antibiotic treatment
multiplex RT-PCR
point-of-care-testing
Journal
Journal of clinical laboratory analysis
ISSN: 1098-2825
Titre abrégé: J Clin Lab Anal
Pays: United States
ID NLM: 8801384
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
received:
05
10
2019
revised:
13
11
2019
accepted:
18
12
2019
pubmed:
8
2
2020
medline:
21
5
2021
entrez:
8
2
2020
Statut:
ppublish
Résumé
Children are commonly affected by respiratory tract infections. Based on clinical symptoms, laboratory evaluation, and imaging, the causative pathogen often cannot be delineated. Point-of-care-testing systems that provide an opportunity for fast detection of common viruses and some bacteria can therefore influence treatment's options. We aimed to examine whether the Biofire® FilmArray® has an effect on antibiotic treatment, duration of antibiotic therapy, and length of hospital stay within a pediatric cohort. We included children who were admitted to inpatient treatment with an acute respiratory tract infection from 02/2017 to 04/2018 using the FA respiratory panel for pathogen detection. The study group data were compared to the retrospective data of children admitted from 02/2016 to 02/2017, using a proprietary multiplex RT-PCR. A total of 322 children of the study group and 464 children of the control group were analyzed for clinical symptoms, laboratory findings, antibiotic treatment, and length of hospital stay. There was no significant reduction (P < .05) of antibiotic treatment and length of hospital stay. CRP, prehospital antibiotic treatment, antibiotic treatment, past medical history, age, and further pathogen detection showed a significant impact on antibiotic therapy, duration of antibiotic treatment, and length of hospital stay. The use of the FA did not result in a significant reduction of antibiotic treatment or in length of hospital stay. Other parameters had a more significant impact. Therefore, we suggest that standard operation procedures with therapy guidelines are necessary to provide an effective application of POCT systems.
Sections du résumé
BACKGROUND
BACKGROUND
Children are commonly affected by respiratory tract infections. Based on clinical symptoms, laboratory evaluation, and imaging, the causative pathogen often cannot be delineated. Point-of-care-testing systems that provide an opportunity for fast detection of common viruses and some bacteria can therefore influence treatment's options. We aimed to examine whether the Biofire® FilmArray® has an effect on antibiotic treatment, duration of antibiotic therapy, and length of hospital stay within a pediatric cohort.
METHODS
METHODS
We included children who were admitted to inpatient treatment with an acute respiratory tract infection from 02/2017 to 04/2018 using the FA respiratory panel for pathogen detection. The study group data were compared to the retrospective data of children admitted from 02/2016 to 02/2017, using a proprietary multiplex RT-PCR.
RESULTS
RESULTS
A total of 322 children of the study group and 464 children of the control group were analyzed for clinical symptoms, laboratory findings, antibiotic treatment, and length of hospital stay. There was no significant reduction (P < .05) of antibiotic treatment and length of hospital stay. CRP, prehospital antibiotic treatment, antibiotic treatment, past medical history, age, and further pathogen detection showed a significant impact on antibiotic therapy, duration of antibiotic treatment, and length of hospital stay.
CONCLUSION
CONCLUSIONS
The use of the FA did not result in a significant reduction of antibiotic treatment or in length of hospital stay. Other parameters had a more significant impact. Therefore, we suggest that standard operation procedures with therapy guidelines are necessary to provide an effective application of POCT systems.
Identifiants
pubmed: 32032458
doi: 10.1002/jcla.23203
pmc: PMC7228252
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e23203Informations de copyright
© 2020 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals, Inc.
Références
J Infect Dis. 2015 Dec 1;212(11):1692-700
pubmed: 25910632
Lancet Respir Med. 2017 May;5(5):401-411
pubmed: 28392237
Open Virol J. 2012;6:151-9
pubmed: 23248735
J Clin Microbiol. 2000 Aug;38(8):2824-8
pubmed: 10921934
Lancet. 2003 Jan 4;361(9351):51-9
pubmed: 12517470
Arch Pathol Lab Med. 2015 May;139(5):636-41
pubmed: 25152311
Clin Microbiol Rev. 2010 Jan;23(1):74-98
pubmed: 20065326
Pediatrics. 2018 Feb;141(2):
pubmed: 29343585
Arch Pediatr Adolesc Med. 2002 Dec;156(12):1230-4
pubmed: 12444835
BMC Infect Dis. 2017 Oct 10;17(1):671
pubmed: 29017451
J Clin Microbiol. 1999 Jan;37(1):1-7
pubmed: 9854054
Diagn Microbiol Infect Dis. 2015 Dec;83(4):400-6
pubmed: 26341706
Clin Infect Dis. 2011 May;52 Suppl 4:S284-9
pubmed: 21460286
Clin Microbiol Rev. 2008 Oct;21(4):716-47
pubmed: 18854489
Scand J Infect Dis. 2008;40(10):821-6
pubmed: 18618373
J Clin Lab Anal. 2020 May;34(5):e23203
pubmed: 32032458
J Clin Microbiol. 2018 May 25;56(6):
pubmed: 29593057
PLoS One. 2017 Feb 24;12(2):e0172809
pubmed: 28235002
Eur J Clin Microbiol Infect Dis. 2018 Apr;37(4):779-783
pubmed: 29332209
Open Microbiol J. 2011;5:128-34
pubmed: 22262985
Wien Klin Wochenschr. 2015 Dec;127 Suppl 5:S255-62
pubmed: 26373742
Cochrane Database Syst Rev. 2017 Feb 09;2:CD003543
pubmed: 28178770
Infection. 2013 Feb;41(1):77-91
pubmed: 22847627
Clin Pediatr (Phila). 2018 Sep;57(10):1224-1226
pubmed: 29096535